I’ve been contemplating a peculiar parallel between two seemingly disparate worlds I inhabit: the precise science of embryo transfers in my IVF practice and the unpredictable art of launching startups as an angel investor. Both experiences, I’ve realized, are steeped in uncertainty, and this uncertainty is an intrinsic part of their respective processes.
The other day, I was in the clinic performing an embryo transfer. As I carefully navigated the catheter, positioning it just right to deposit an embryo into the uterine cavity, I was struck by the delicate balance of science and uncertainty. Despite our best efforts, the outcome isn’t guaranteed. An embryo can look perfect under the microscope, yet there are factors beyond our control that determine whether it will implant and grow into a healthy pregnancy. There’s a magic—and frustration—in that unpredictability.
Similarly, when I consider the startups I back, I see the same blend of calculated preparations subject to forces beyond anyone’s control. I recall a promising founder I recently mentored. Her startup had ticked all the right boxes—solid market research, a competent team, and a prototype that worked beautifully. Yet, as with an embryo, the transition from potential to reality is fraught with challenges. Market dynamics shift, consumer preferences evolve, and economic conditions fluctuate. The best-laid plans can unravel, and success is never assured.
In both domains, we crave certainty, yet we’re forced to embrace ambiguity. An AI tool like Gaia’s, which predicts IVF success with 90% accuracy, offers a semblance of control over the uncontrollable. It’s a reminder that while technology can provide guidance, it doesn’t eliminate uncertainty. The same holds true in the startup ecosystem, where data-driven insights can guide decisions but can’t predict every market twist and turn.
One might argue that this uncertainty is what makes both fields exhilarating. It’s the possibility of success against the odds that drives us. However, it also demands resilience, an acceptance of failure, and an unwavering commitment to try again. In my experience, the best IVF patients and the most resilient founders share these traits: they are prepared to endure setbacks and remain committed despite the odds.
I’ve often found that the lessons from one field enrich my understanding of the other. My medical practice has taught me the importance of patience and meticulous preparation, attributes that are equally valuable when nurturing a startup. Conversely, the agility and adaptability required in the startup world have enhanced my approach to patient care, where each case is unique and demands a tailored approach. I’ve written about this cross-pollination of insights in my post on how my medical background enriches my startup decisions.
Risk-taking is another shared theme. Patients embarking on IVF are taking a leap of faith, much like entrepreneurs launching a business. Both are investing time, money, and emotional energy into an uncertain outcome. Yet, without taking these risks, the possibility of success remains out of reach. This is a theme I’ve explored further in my post on when startups mirror the uncertainty of fertility treatments.
Both embryo transfers and startup launches also require a certain level of detachment. As much as we invest in them, we must also prepare for the possibility that they might not succeed. This detachment doesn’t mean indifference; rather, it’s an acceptance of the limits of our influence. I’ve learned to focus on the process rather than the outcome, ensuring that every step is executed with precision and care. This mindset not only preserves my sanity but also enhances my ability to support patients and founders through their journeys.
At the end of the day, both fields teach us about the human aspect of endeavor. Behind every embryo transfer and startup launch, there are real people with hopes, dreams, and fears. The emotional stakes are high, and part of my role in both capacities is to provide reassurance and guidance, helping them navigate the rollercoaster of emotions that accompany these ventures. This is why, despite the uncertainty, I continue to be drawn to both worlds. They remind me of the resilience of the human spirit and the relentless pursuit of possibilities.
In conclusion, whether it’s guiding an embryo or a startup to fruition, the journey is marked by uncertainty and the potential for failure. But it’s also filled with hope, resilience, and the thrill of what might be possible. And perhaps, that’s what makes it all worthwhile.
So, as I continue to traverse the paths of IVF and angel investing, I find solace in their shared uncertainties. They teach me patience, humility, and the value of hope. In embracing these lessons, I strive to be a better doctor, a more insightful investor, and a more empathetic human being.